Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Irene Kührer
Observed names:
I Kührer,
I. Kührer,
Irene Kuhrer
Institution:
Medical University of Vienna
Observed institutions:
University of Vienna,
Comprehensive Cancer Center Vienna,
Wilhelminen Hospital,
St Anna Children's Hospital,
Universitätsklinik für Chirurgie Wien,
Medical University of Vienna
show all 6
OpenAlex ID:
A5111419996
Erythropoietin treatment for chronic anemia of selected hematological malignancies and solid tumors
1993
·
H. Ludwig
, E. Fritz
, et al.
·
Annals of Oncology
·
94
PDF
TP53 Genotype but Not p53 Immunohistochemical Result Predicts Response to Preoperative Short-Term Radiotherapy in Rectal Cancer
2002
·
Daniela Kandioler
, Ronald Zwrtek
, et al.
·
Annals of Surgery
·
90
TP53 Mutational Status and Prediction of Benefit from Adjuvant 5-Fluorouracil in Stage III Colon Cancer Patients
2015
·
Daniela Kandioler
, Martina Mittlböck
, et al.
·
EBioMedicine
·
56
The biomarker TP53 divides patients with neoadjuvantly treated esophageal cancer into 2 subgroups with markedly different outcomes. A p53 Research Group study
2014
·
Daniela Kandioler
, Sebastian F. Schoppmann
, et al.
·
Journal of Thoracic and Cardiovascular Surgery
·
50
PDF
Growing clinical evidence for the interaction of the p53 genotype and response to induction chemotherapy in advanced non–small cell lung cancer
2008
·
Daniela Kandioler
, Georgios Stamatis
, et al.
·
Journal of Thoracic and Cardiovascular Surgery
·
49
PDF
The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group.
1998
·
C Bokemeyer
, A Harstrick
, et al.
·
PubMed
·
47
Risk factors for bilateral testicular germ cell tumors. Does heredity play a role?
1991
·
C. Kratzik
, P. Aiginger
, et al.
·
Cancer
·
35
Topical Pge2 Enhances Healing of Chemotherapy-associated Mucosal Lesions
1986
·
I. Kührer
, R. Kuzmits
, et al.
·
The Lancet
·
35
Assessing the TP53 marker type in patients treated with or without neoadjuvant chemotherapy for resectable colorectal liver metastases: A p53 Research Group study
2015
·
N. Pilat
, T. Grünberger
, et al.
·
European Journal of Surgical Oncology
·
28
The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors
1998
·
C. Bokemeyer
, A. Harstrick
, et al.
·
Seminars in Oncology
·
25
Erythropoietin treatment of chronic anaemia of cancer
1993
·
H. Ludwig
, C. Leitgeb
, et al.
·
European Journal of Cancer
·
21
Combined alpha-2C-interferon/VMCP polychemotherapy versus VMCP polychemotherapy as induction therapy in multiple myeloma: a prospective randomized trial.
1989
·
W Scheithauer
, A Cortelezzi
, et al.
·
PubMed
·
12
Carboplatin-Monotherapie bei Seminomen im Stadium I
1993
·
Ch. Kratzik
, Irene Kührer
, et al.
·
European surgery. Supplement/European surgery
·
11
Turning the tables on surgical oncology: the • Pancho trial unplugged
2008
·
S. Kappel
, C. Bichler
, et al.
·
European surgery. Supplement/European surgery
·
8
Secondary migration: a complication of Hickman central venous catheters.
1996
·
M Muhm
, G Sunder-Plassmann
, et al.
·
PubMed
·
8
Kinetics of PBPC mobilization by cyclophosphamide, as compared with that by epirubicin/paclitaxel followed by G–CSF support: implications for optimal timing of PBPC harvest
2001
·
Markus Dettke
, Hildegard T. Greinix
, et al.
·
Transfusion
·
6
First-Line High-Dose Chemotherapy for ’Poor Risk’ Metastatic Non-Seminomatous Testicular Germ Cell Tumors
1998
·
C. Bokemeyer
, A. Harstrick
, et al.
·
Oncology Research and Treatment
·
6
• Pancho trial (p53-adapted neoadjuvant chemotherapy for resectable esophageal cancer) completed—mutation rate of the marker higher than expected
2018
·
Sonja Kappel-Latif
, Johannes Zacherl
, et al.
·
European surgery. Supplement/European surgery
·
5
PDF
Combined Interferon-Polychemotherapy versus Polychemotherapy in Multiple Myeloma: A Phase-III Study
1987
·
H. Ludwig
, A. Cortelezzi
, et al.
·
Springer eBooks
·
5
Der Einfluß verschiedener Faktoren auf das Überleben des rezidivierenden und/oder metastasierenden Mammakarzinoms
1991
·
P. Sevelda
, I. Kührer
, et al.
·
Geburtshilfe und Frauenheilkunde
·
3
TP53 is not a prognostic marker—clinical consequences of a generally disregarded fact
2018
·
Tamara Braunschmid
, Irene Kührer
, et al.
·
Annals of the New York Academy of Sciences
·
2
PDF
EFR and the European code against cancer – working together for a healthier future in the enlarged European Union
2006
·
Irene Kührer
, Béla Teleky
·
European surgery. Supplement/European surgery
·
2
Transnasale Sonde oder perkutane endoskopische Gastrostomie zur Ernährung von Patienten im Greisenalter – Indikationen, Technik und Ergebnisse
2003
·
B. Telky
, I. Kührer
, et al.
·
Visceral Medicine
·
2
369. Assessing the predictive and prognostic value of the biomarker TP53 in patients with resectable colorectal liver metastases treated with and without neoadjuvant fluorouracil based chemotherapy: A p53 research group study
2014
·
N.P. Pilat
, T. Grünberger
, et al.
·
European Journal of Surgical Oncology
·
1
PART 1 – p53 adapted preoperative radiotherapy for T2 and T3 rectal cancer. A study of the p53 research group
2010
·
B. Wolf
, I. Kührer
, et al.
·
European surgery. Supplement/European surgery
·
1
Show more works
View as search
Works count:
51
Citation count:
608
H-index:
12
I10-index:
13
Year
Topic
Type